The in vitro and ex vivo effect of Auranta 3001 in preventing Cryptosporidium hominis and Cryptosporidium parvum infection
Crossref DOI link: https://doi.org/10.1186/s13099-017-0192-y
Published Online: 2017-08-31
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ch Stratakos, Alexandros
Sima, Filip
Ward, Patrick
Linton, Mark
Kelly, Carmel
Pinkerton, Laurette
Stef, Lavinia
Pet, Ioan
Iancu, Tiberiu
Pircalabioru, Gratiela
Corcionivoschi, Nicolae
Funding for this research was provided by:
Auranta